Results 91 to 100 of about 33,530 (249)

Overview of Epidemiology, Pathophysiology, Risk factors, Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension

, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH) is one of the curable forms of pulmonary hypertension, but CTEPH can be lethal without treatment.
Kitahara, Mari
core  

Chronic thromboembolic pulmonary hypertension in pediatric patients

, 2011
ObjectiveChronic thromboembolic pulmonary hypertension is a rare form of pulmonary hypertension that can lead to progressive right heart failure and death.
Kriett, Jolene M., Jamieson, Stuart W., Kerr, Kim M., Jolene M. Kriett, Auger, William R., Fedullo, Peter F., Kim M. Kerr, Madani, Michael M., Test, Victor J., Nick H. Kim, Peter F. Fedullo, Michael M. Madani, Lara M. Wittine, Victor J. Test, Stuart W. Jamieson, William R. Auger, Kim, Nick H., Wittine, Lara M.   +17 more
core   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature

Frontiers in Cardiovascular Medicine
IntroductionPrimary immune thrombocytopenia is an autoimmune bleeding disorder characterized by variable immune-mediated platelet destruction. These patients have reported thrombotic complications, both venous and arterial, in addition to bleeding ...
Roberto Castelli, Enrico Atzori, Alessandro Palmerio Delitala, Salvatore Antonio Masala, Valentina Micheluzzi, Enrico Ponti, Enrico Ponti, Giuseppe Sanna, Dante Castro, Antonio Gidaro, Mattia Donadoni, Roberto Manetti, Pierluigi Merella, Nicia Isabella Profili, Andrea Maria D'Armini, Gavino Casu, Gavino Casu   +16 more
doaj   +1 more source

Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension

, 2013
Conclusion: Pulmonary endarterectomy is effective and safe in the treatment of chronic thromboembolic pulmonary hypertension.
Mehmet Yanartas, Saçlı, Hakan, Mahmut Kis, Hasan Sunar, Bedrettin Yildizeli, Burcin Cayhan, Cihangir Kaymaz, Serpi Tas, Tuncer Kocak   +8 more
core   +1 more source

Persistent exercise intolerance after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

, 2020
AIM: Haemodynamic normalisation is the ultimate goal of pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH). However, whether normalisation of haemodynamics translates into normalisation of exercise capacity is ...
Symersky, Petr, Bogaard, Harm-Jan, Vonk Noordegraaf, Anton, Ruigrok, Dieuwertje, Nossent, Esther J, Boonstra, Anco, Braams, Natalia J, van Wezenbeek, Jessie, Meijboom, Lilian J, de Man, Frances S, Marcus, J Tim   +10 more
core   +1 more source

Cardiotoxicity of BRAF/MEK inhibitors

British Journal of Pharmacology, EarlyView.
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe, Valerie Lohner, Kevin Terre, Thomas Riffelmacher, Roman Pfister   +4 more
wiley   +1 more source

Effects of pulmonary endarterectomy on pulmonary hemodynamics in chronic thromboembolic pulmonary hypertension, evaluated by interventricular septum curvature

Pulmonary Circulation, 2020
The interventricular septum curvature, measured in images of electrocardiogram-gated 320-slice multidetector computed tomography, is reportedly useful and less invasive than right heart catheterization, as it could provide clues regarding pulmonary ...
Takahiko Saito, Hajime Kasai, Toshihiko Sugiura, Yukiko Takahashi, Hiroshi Tajima, Ayako Shigeta, Seiichiro Sakao, Nobuhiro Tanabe, Koichiro Tatsumi   +8 more
doaj   +1 more source

Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism

Рациональная фармакотерапия в кардиологии, 2020
After suffering pulmonary embolism (PE), doctors are confronted with various consequences of the disease, from asymptomatic residual pulmonary thrombosis to the formation of chronic thromboembolic pulmonary hypertension (CTEPH).
A. A. Klimenko, N. A. Demidova, N. A. Shostak, M. O. Anischenko   +3 more
doaj   +1 more source

Chronic thromboembolic pulmonary hypertension after the first episode of pulmonary embolism? How often?

Biomedical Papers, 2016
Background: Surviving pulmonary embolism (PE) brings a risk of thromboembolic disease chronicity. Chronic thromboembolic pulmonary hypertension (CTEPH) develops as a result of one or multiple pulmonary embolic events.
Zdenek Vavera, Jan Vojacek, Radek Pudil, Jaroslav Maly, Pavel Elias   +4 more
doaj   +1 more source